| | Business Summary | | Medisys
Technologies,
Inc.
is
a
development
stage
corporation
focused
on
the
commercialization
of
CoverTip
hypodermic
safety
syringe
and
other
sharps
related
medical
devices.
The
Company
owns
a
total
of
20
U.S.
and
foreign
patents
covering
medical
safety
devices
and
other
products
that
offer
proprietary,
high-potential
technology,
and
has
additional
patent
applications
pending
for
its
medical
devices
in
both
the
U.S.
and
overseas.
The
Company
is
a
diversified
medical
device
company
with
a
business
strategy
to
design
and
develop
products
that
address
concerns
about
safety. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | SCEP
is
a
development
stage
company
with
a
focus
on
the
delivery
of
innovative,
cost-effective
products
to
the
Women's
Healthcare
and
Medical
Safety
Device
markets.
For
the
three
months
ended
3/31/01,
revenues
totaled
$0,
down
from
$623.
Net
loss
from
continuing
operations
fell
60%
to
$1.3
million.
Revenues
reflect
the
elimination
of
the
operations
of
Phillips
Pharmatech
Labs,
Inc.
Net
loss
reflects
lower
S/G/A
expenses
due
to
a
reduction
in
product
introduction
costs. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Paul Ray, 54
Chairman | -- | Edward Sutherland, 54
CEO,
Director | $200K | Kerry Frey, 55
Pres,
COO, Director | 194K | Robert McNabb
Treasurer | -- | William David Kiesel, 56
Sec.,
Director | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/s/scep.ob.gif)